By Stephen Nakrosis LumiraDx said Friday it will sell certain companies related to its point-of-care technology to Roche. Andrew Johnson, Lisa Rickelton and.
By Emon Reiser Shares of Silo Pharma declined after the developmental-stage biopharmaceutical company said its partner received regulatory approval to begin.
By Colin Kellaher Shares of Bluejay Diagnostics tumbled nearly 35% in premarket trading Thursday after the medical-technology company said it was raising.
By Anthony O. Goriainoff Novacyt said that completion of the sale of its Taiwan laboratory will take longer than anticipated and won't be completed before.